Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- ChecktodayChange DetectedThe page’s “Revision” identifier was updated from v3.5.2 to v3.5.3. This reflects a platform/version update without changing the study record content shown.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a system-level version update and does not alter study content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPadua, Italy 35128 was removed from the locations and Padova, Italy 35128 was added to the locations.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a frontend build/version change with no visible alterations to study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.4.3 implemented, replacing the previous v3.4.2.SummaryDifference0.0%

- Check72 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 revision was removed, indicating an administrative update to study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.